Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP292754.RAWMXM8y8Ru3MkW8A_wI9LXUwSOtVYng6svZJGLw2bJGM130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292754.RAWMXM8y8Ru3MkW8A_wI9LXUwSOtVYng6svZJGLw2bJGM130_provenance.
• NP545281.RASPbX-yUdPa39XZeIFdUFoYk5WScpB63Xo2ZptisfoN8130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545281.RASPbX-yUdPa39XZeIFdUFoYk5WScpB63Xo2ZptisfoN8130_provenance.
• NP172669.RAmmkggLF9-8CWIJA5enMLVoVaNovY8ZePKfTA-GtylX0130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172669.RAmmkggLF9-8CWIJA5enMLVoVaNovY8ZePKfTA-GtylX0130_provenance.
• NP721912.RAj4oQFoTrO1VU5NoIp_ekq7a1q4N6t9UqDa7ZQ4nSWNI130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721912.RAj4oQFoTrO1VU5NoIp_ekq7a1q4N6t9UqDa7ZQ4nSWNI130_provenance.
• NP932690.RAmOGdTqgNOr8iKXgq5I3FWhxgkYgfFVuLAPTqbgm6fGM130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932690.RAmOGdTqgNOr8iKXgq5I3FWhxgkYgfFVuLAPTqbgm6fGM130_provenance.
• NP326263.RADE8lB1SMrVqNiYa_KJoRu8JDu2Tja6yL6jsQQsl3SFg130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326263.RADE8lB1SMrVqNiYa_KJoRu8JDu2Tja6yL6jsQQsl3SFg130_provenance.
• NP532451.RAMdEXvGTQnl98K6fx74trlzJN4iNZr90ieWm2f-yKNvE130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532451.RAMdEXvGTQnl98K6fx74trlzJN4iNZr90ieWm2f-yKNvE130_provenance.
• NP556635.RAEmAy4Ffr5eNE3ES0358B4MY910xia0UfbY6Q7jVT1B0130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556635.RAEmAy4Ffr5eNE3ES0358B4MY910xia0UfbY6Q7jVT1B0130_provenance.
• NP326481.RA6ro5VRJPaXjgTIRZNtK-6UObz2x4DHoEd58UT5KQhso130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326481.RA6ro5VRJPaXjgTIRZNtK-6UObz2x4DHoEd58UT5KQhso130_provenance.
• NP830280.RAIRdK79p47h9MGwAMJCIafuNONFMu71Um-P7BnDmWjNg130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830280.RAIRdK79p47h9MGwAMJCIafuNONFMu71Um-P7BnDmWjNg130_provenance.
• NP326411.RA9aiUqouXOmm3D1OhUPurZP0uiyha_UpOyhqfe2tMyiI130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326411.RA9aiUqouXOmm3D1OhUPurZP0uiyha_UpOyhqfe2tMyiI130_provenance.
• NP326442.RA4Vd4ygXXTormRMpB_ZwbnT6T6ldnRGzL6UKam7ctFTU130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326442.RA4Vd4ygXXTormRMpB_ZwbnT6T6ldnRGzL6UKam7ctFTU130_provenance.
• NP326491.RAP-QOE0sIymiD0_8GV0s10ONG1gw_SuPeT4t5ciBmRbI130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326491.RAP-QOE0sIymiD0_8GV0s10ONG1gw_SuPeT4t5ciBmRbI130_provenance.
• NP1090957.RATpBQvL-WnU_6UTar6nrUhaULtvbyEK_uqpi_0lr_DDM130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090957.RATpBQvL-WnU_6UTar6nrUhaULtvbyEK_uqpi_0lr_DDM130_provenance.
• NP1090961.RAY_s9NywPg8cgx4yaDjknUUYOS_joCG39UQj3td5y5vk130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090961.RAY_s9NywPg8cgx4yaDjknUUYOS_joCG39UQj3td5y5vk130_provenance.
• NP1090962.RASlDOvU7uxeQ1COCkXdsiqt8YBU42OwQsxnmDpTvgdPo130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090962.RASlDOvU7uxeQ1COCkXdsiqt8YBU42OwQsxnmDpTvgdPo130_provenance.
• NP326384.RAn2JQnA5KrxaoxexAdO4_R9DjAsuSqcAhTk93uLQGsIM130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326384.RAn2JQnA5KrxaoxexAdO4_R9DjAsuSqcAhTk93uLQGsIM130_provenance.
• NP1090959.RAthaZcWgYvJj90ZyldriLoz_9OaptJ5kPNDTYtd6-rc0130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090959.RAthaZcWgYvJj90ZyldriLoz_9OaptJ5kPNDTYtd6-rc0130_provenance.
• NP1090960.RAmi0N41kq67SG8PBPqie0oGhG9BsC-ucYk_VO2CChGjk130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090960.RAmi0N41kq67SG8PBPqie0oGhG9BsC-ucYk_VO2CChGjk130_provenance.
• NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.